10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0000946644-14-000017`
Period End Date	20140630
Filing Date	20140808
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	heb-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 2 Cash Flow Statement 60 Stockholders Equity 9 Comprehensive Income 69

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.62M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.31M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$17.59M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$17.39M	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$246.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$358.00K	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$20.46M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$18.55M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	189.50M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	168.66M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.05M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.84M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	168.66M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	189.50M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.08M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$924.00K	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$7.19M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$7.05M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$136.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00K	USD	Point-in-time
Total assets	`Assets`	$33.55M	USD	Point-in-time
Total assets	`Assets`	$31.87M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.47M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.66M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.23M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$31.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$33.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.53M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.16M	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$23.00K	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$7.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$13.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$14.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.57M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.18M	USD	Point-in-time
Commitments and contingencies (Notes 6, 8, 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 6, 8, 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 189,498,664 and 168,660,370, respectively	`CommonStockValue`	$168.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 189,498,664 and 168,660,370, respectively	`CommonStockValue`	$189.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$298.24M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$289.56M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$54.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-114.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-260.32M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-269.11M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.37M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$31.87M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$33.55M	USD	Point-in-time

Income Statement 2 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-8.79M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-7.89M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-4.28M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.96M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$350.00K	USD	2 Qtrs
Depreciation of property and equipment	`Depreciation`	$332.00K	USD	2 Qtrs
Amortization and abandonment of patent and trademark rights	`AdjustmentForAmortization`	$87.00K	USD	2 Qtrs
Amortization and abandonment of patent and trademark rights	`AdjustmentForAmortization`	$276.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$1.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$1.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$191.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$102.00K	USD	1 Quarter
Equity-based compensation	`StockOptionPlanExpense`	$219.00K	USD	2 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$198.00K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	-	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-453.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-112.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$37.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.03M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$238.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.59M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.43M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.63M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.21M	USD	2 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$534.00K	USD	2 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$266.00K	USD	2 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$122.00K	USD	2 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$120.00K	USD	2 Qtrs
Deposits on capital leases refunded	`ProceedsfromRefundedCapitalLeaseDeposits`	$3.00K	USD	2 Qtrs
Deposits on capital leases refunded	`ProceedsfromRefundedCapitalLeaseDeposits`	$2.00K	USD	2 Qtrs
Deposit paid on office lease	`PaymentsforOfficeLeaseDeposits`	-	USD	2 Qtrs
Deposit paid on office lease	`PaymentsforOfficeLeaseDeposits`	$74.00K	USD	2 Qtrs
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$9.48M	USD	2 Qtrs
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	2 Qtrs
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	2 Qtrs
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$36.00K	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$8.75M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-420.00K	USD	2 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$29.00K	USD	2 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$18.00K	USD	2 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$8.46M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$8.44M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-29.00K	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.81M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-906.00K	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.62M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.31M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.62M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$803.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.31M	USD	Point-in-time
Issuance of common stock for accounts payable	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$38.00K	USD	2 Qtrs
Issuance of common stock for accounts payable	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$164.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.04M	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$168.00K	USD	2 Qtrs
Cash paid for interest expense and capitalized construction interest	`InterestPaid`	$-9.00K	USD	2 Qtrs
Cash paid for interest expense and capitalized construction interest	`InterestPaid`	$-98.00K	USD	2 Qtrs

Stockholders Equity 9 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.30M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.37M	USD	Point-in-time
Stock issued for settlement of accounts payable	`StockIssuedForSettlementOfAccountsPayable`	$38.00K	USD	2 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$198.00K	USD	2 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$219.00K	USD	2 Qtrs
Stock sold at the market	`StockIssuedDuringPeriodValueNewIssues`	$8.46M	USD	2 Qtrs
Net comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-8.62M	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.30M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$29.37M	USD	Point-in-time

Comprehensive Income 69 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`SalesRevenueGoodsNet`	$36.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$112.00K	USD	2 Qtrs
Clinical treatment programs	`SalesRevenueGoodsNet`	$78.00K	USD	2 Qtrs
Clinical treatment programs	`SalesRevenueGoodsNet`	$36.00K	USD	1 Quarter
Total revenues	`Revenues`	$112.00K	USD	2 Qtrs
Total revenues	`Revenues`	$36.00K	USD	1 Quarter
Total revenues	`Revenues`	$36.00K	USD	1 Quarter
Total revenues	`Revenues`	$78.00K	USD	2 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$617.00K	USD	2 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$635.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$826.00K	USD	2 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$294.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.65M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.66M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.32M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.33M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.89M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$5.04M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.50M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.82M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$9.37M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$4.77M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$5.12M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$10.31M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-4.73M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-9.30M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-10.20M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-5.08M	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$5.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$6.00K	USD	2 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$10.00K	USD	2 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$3.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$354.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$131.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$284.00K	USD	2 Qtrs
Interest and other income	`OtherInterestAndDividendIncome`	$535.00K	USD	2 Qtrs
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$686.00K	USD	2 Qtrs
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	-	USD	1 Quarter
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.13M	USD	Point-in-time
Gain from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.13M	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$1.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$1.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$191.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$102.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.79M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-7.89M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-4.28M	USD	1 Quarter
Net loss	`ProfitLoss`	$-4.96M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$147.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-1.00M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$168.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-960.00K	USD	2 Qtrs
Reclassification adjustments for impairment losses included in net loss	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$76.00K	USD	1 Quarter
Reclassification adjustments for impairment losses included in net loss	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$85.00K	USD	2 Qtrs
Reclassification adjustments for impairment losses included in net loss	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	2 Qtrs
Reclassification adjustments for impairment losses included in net loss	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-8.62M	USD	2 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-8.94M	USD	2 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.81M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-5.36M	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	2 Qtrs
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	2 Qtrs
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	185.75M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	167.01M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	167.20M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	181.27M	shares	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.